1-(2,2,2-Trifluoro-ethyl)-1H-pyrazol-3-ylamine hydrochloride, 95.0%, 1g

3,3'-(5'-(3-(Pyridin-3-yl)phenyl)-[1,1':3',1''-terphenyl]-3,3''-diyl)dipyridine, 97%, 5g

N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 98%, 1g

Ethylene Glycol Monohexyl Ether [for Biochemical Research]>98.0%(GC)1mL

1,2-Bis(4-(3-phenylpropyl)piperidin-1-yl)ethane, 97%, 5g

2-(4-Bromothiazol-2-yl)acetonitrile, 98%, 250mg

2-(3-Cyano-1H-1,2,4-triazol-1-yl)acetic acid, 97%, 5g

2,5-Dibromo-4-methylthiazole, 95.0%, 25g

5,6-Dihydroxy-2,3-dihydro-1H-inden-1-one, 95.0%, 5g

METHYL 7-BROMO-3-FORMYL-1-ISOPROPYL-1H-INDOLE-4-CARBOXYLATE, 95.0%, 250mg

4-Methyl-4-nitrovaleraldehyde>90.0%(GC)25g

Sodium (Z)-5-(2-carbamoylhydrazono)-1-methyl-6-oxo-2,3,5,6-tetrahydro-1H-indole-2-sulfonate, 95.0%, 100g

1-Benzyl-3-hydroxy-1H-indazole, 95.0%, 5g